Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Alirocumab
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Praluent 150mg/1ml solution for injection pre-filled pens
0212000AIBBABAB
|
Praluent | Alirocumab | Cardiovascular System | 187 |
|
Praluent 75mg/1ml solution for injection pre-filled pens
0212000AIBBAAAA
|
Praluent | Alirocumab | Cardiovascular System | 126 |
|
Alirocumab 150mg/1ml inj pre-filled disposable devices
0212000AIAAABAB
|
Alirocumab | Alirocumab | Cardiovascular System | 30 |
|
Alirocumab 75mg/1ml inj pre-filled disposable devices
0212000AIAAAAAA
|
Alirocumab | Alirocumab | Cardiovascular System | 24 |
|
Alirocumab 300mg/2ml inj pre-filled disposable devices
0212000AIAAACAC
|
Alirocumab | Alirocumab | Cardiovascular System | 3 |
|
Praluent 300mg/2ml solution for injection pre-filled pens
0212000AIBBACAC
|
Praluent | Alirocumab | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.